MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
OPGN - Opgen Inc
$1.92
-0.02(-1.03%)8:00:00 PM 10/21/2021
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company's products include Acuitas AMR Gene Panel, a vitro diagnostic test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance in urine specimens or bacterial colonies isolated from urine and other body sites; and QuickFISH and PNA FISH products, which are FDA-cleared and CE-marked diagnostic test designed to detect pathogens in positive blood cultures. In addition, it offers Acuitas Lighthouse informatics systems, a cloud-based HIPAA compliant informatics offerings, which combine clinical lab test results with patient and hospital information, and provide analytics and insights to enable manage MDROs in the hospital and patient care environment. OpGen, Inc. has a strategic collaboration with the New York State Department of Health to develop a solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

No summary
Related Topics
Peers

Stock news

    10/21/2021OPGN
    OpGen Subsidiary Ares Genetics Launches AREScloud

    AREScloud is a new, commercial web application aimed at accelerating the analysis of sequenced clinical isolatesAREScloud offers an advanced solution for infection prevention and control ROCKVILLE, Md., Oct. 21, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, today announced that its subsidiary Ares Genetics, which strives to become a leader in bacterial gen

    10/18/2021OPGN
    OpGen Announces Closing of $15 Million Registered Direct Offering

    ROCKVILLE, Md., Oct. 18, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced the closing of its previously announced registered direct offering with a single healthcare-focused institutional investor of 150,000 shares of convertible preferred stock and warrants to purchase up to an aggregate of 7,500,000 shares of common stock

    10/14/2021OPGN
    OpGen Announces $15 Million Registered Direct Offering

    ROCKVILLE, Md., Oct. 14, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the issuance and sale of an aggregate of 150,000 shares of convertible preferred stock and warrants to purchase up to an aggregate of 7,500,000

    10/5/2021OPGN
    44 Biggest Movers From Yesterday

    Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares climbed 101.9% to close at $31.50 on Monday after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints. Elmira Savings Bank (NASDAQ: ESBK) gained 68.2% to close at $22.70 after the company announced it would be acquired by Community Bank System. Mexco Energy Corporation (NYSE: MXC) rose 46.4% to settle at $16.97 after OPEC+ agreed to stay with an existing pact to increase

    10/4/2021OPGN
    Rockville biotech lands federal approval for superbug testing system

    The diagnostic aims to help doctors recognize drug resistance early in infections to help inform treatment decisions.

    10/4/2021OPGN
    Mid-Day Market Update: Nasdaq Down 2%; Xenon Pharmaceuticals Shares Jump

    Midway through trading Monday, the Dow traded down 1.02% to 33,976.93 while the NASDAQ fell 2.14% to 14,255.08. The S&P also fell, dropping 1.23% to 4,303.43. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 43,683,760 cases with around 701,170 deaths. India confirmed a total of at least 33,834,700 cases and 448,990 deaths, while Brazil reported over 21,468,120 COVID-19 cases with 597,940 deaths. In total, there were at least 234,977,030 cases of

    10/4/2021OPGN
    30 Stocks Moving In Monday's Mid-Day Session

    Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares jumped 71.1% to $26.69 after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints. Elmira Savings Bank (NASDAQ: ESBK) surged 67.3% to $22.59 after the company announced it would be acquired by Community Bank System. Otonomo Technologies Ltd. (NASDAQ: OTMO) shares gained 22.9% to $6.02. OpGen, Inc. (NASDAQ: OPGN) climbed 19.9% to $3.3050 after the company announced it recei

    10/4/2021OPGN
    5 Top Stock Gainers for Monday: Ford, General Motors, Xenon

    Ford, General Motors, Xenon Pharmaceuticals, Opgen and Silgan Holdings are five top stock gainers for Monday.